Robot-assisted sacrocolpopexy for recurrent pelvic organ prolapse: Insights for a challenging surgical setting - 20/05/22

Doi : 10.1016/j.jogoh.2022.102380

Thomas Dabreteau ^a,^b, Romain Delangle ^a, Henri Azaïs ^a, Véronique Phé ^c, Gaby Moawad ^d, Catherine Uzan ^a,^e, Geoffroy Canlorbe ^a,^e,^⁎
^a Sorbonne University, Assistance Publique des Hôpitaux de Paris (AP-HP), Department of Gynecological and Breast Surgery and Oncology, Pitié-Salpêtrière University Hospital, Paris 75013, France
^b Sorbonne Université, CNRS UMR 7222, INSERM U1150, Institut des Systèmes Intelligents et Robotique (ISIR), Paris 75005, France
^c Sorbonne University, Assistance Publique des Hôpitaux de Paris (AP-HP), Department of Urology, Pitié-Salpêtrière Academic Hospital, Paris 75013, France
^d Department of Obstetrics and Gynecology, George Washington University, 900 23rd St NW, Washington, DC 20037, United States of America
^e Sorbonne University, Cancer Biology and Therapeutics, Centre de Recherche Saint-Antoine (CRSA), INSERM UMR_S_938, Paris 75020, France

^⁎Corresponding author.

Abstract

Background: No consensus exists regarding the management of recurrent pelvic organ prolapse (POP). The aim of this study was to evaluate robot-assisted laparoscopic sacrocolpopexy for recurrent pelvic organ prolapse (POP), and to investigate postoperative outcomes.

Methods: We conducted a single-center retrospective study including 10 consecutive patients who underwent a robot-assisted sacrocolpopexy for symptomatic POP recurrence from February 2017 to December 2019. Recurrence rates and patient satisfaction, measured by the Pelvic Floor Impact Questionnaire (PFIQ-7) were recorded.

Results: Median age was 57 years (IQR: 54–67). No intraoperative complications were reported. The median hospital stay after surgery was 2 nights (IQR: 1–4). Two patients (20%) experienced early recurrence: at 1 month for one and at 4.5 months for the other. The median follow-up for the remaining eight patients was 18 months (IQR: 12–23). Among the recurrence-free patients, the median PFIQ-7 score was 11.4 at 12 months.

Conclusions: Robot-assisted sacrocolpopexy is feasible and safe for the management of POP recurrence, with a high patient satisfaction.

Le texte complet de cet article est disponible en PDF.

Keywords : Sacrocolpopexy, Pelvic organ prolapse, Robot-assisted laparoscopy, Recurrence, Minimally invasive surgery

Mots-clés : POP, Pelvic organ prolapse

Plan

Export

Vol 51 - N° 6

Article 102380- juin 2022 Retour au numéro

Article précédent

Uterine hemangioma in pregnancy: A case report and review of the literature
Emma Bauters, Michael Aertsen, Wouter Froyman, Johannes van der Merwe

| Article suivant

Definition, general principles and expected benefits of enhanced recovery in surgery
Arthur Foulon, Raffaele Fauvet, Vincent Villefranque, Nicolas Bourdel, Thérèse Simonet, Christine Louis Sylvestre, Geoffroy Canlorbe, Henri Azaïs

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

connectez-vous ou créez un compte

Robot-assisted sacrocolpopexy for recurrent pelvic organ prolapse: Insights for a challenging surgical setting - 20/05/22

Abstract

Plan

Export citations

Fichier

Contenu

Accès rapides

Mon compte

Aide & support

Plateformes Elsevier Masson

Déclaration CNIL